Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:
- We asked experts what to make of the J&J vaccine pause;
- Our reporter tried to find out how much it’d cost to get an MRI – and it turned into a real headache;
- Microsoft’s $16 billion bid for Nuance gets it in on the ground floor of healthcare.
Doctors say fears of blood clots from J&J’s shot are overdone and could delay the push to end the pandemic
- Coronavirus vaccines are facing their biggest safety scare to date.
- A small number of people immunized with Johnson & Johnson’s or AstraZeneca’s shot developed serious blood clots.
- Medical experts say a blow to public confidence in vaccination is a graver threat than the actual adverse events.
A new rule was supposed to force hospitals to reveal their secret prices. But after I spent hours shopping around for an MRI, I learned that not much has changed.
- Starting January 1, hospitals were supposed to publish prices they negotiate with insurers.
- To see whether the process had gotten easier, reporter Shelby Livingston tried finding prices for an MRI at nearby hospitals.
- She was unable to easily compare MRI prices, as most hospitals neglected to post negotiated rates.
- Microsoft is buying Nuance Communications to bulk up its healthcare services.
- Nuance is best known for conversational AI that helps doctors with notes.
- Microsoft stands to work with more than half of US physicians when the deal goes through.
More stories we’re reading:
- JOIN US THURSDAY FOR A LIVE EVENT: Experts answer your questions about coronavirus vaccines and the risk of rare, serious blood clots (Insider)
- Researchers are puzzling over what to make of the link between COVID-19 vaccines and blood clots (Stat News)
- What to do if you got the Johnson & Johnson vaccine amid blood clot fears (Insider)
- Meet the billionaire who built an empire out of electronic medical records (Forbes)
- New data shows Moderna’s vaccine remains highly protective 6 months after shots (Insider)